| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 |
| filingDate |
1984-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb23a4105cecf5d0672e82a5401e3a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719616654f04ab0f54f759afc5b90e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1690fc564ad17f85e265db92069b6db6 |
| publicationDate |
1986-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2161486-A |
| titleOfInvention |
Novel 1-methyl-4,5-dihydroorotic acid derivative and processes for preparing the same |
| abstract |
1-methyl-4,5-dihydroorotyl-histidyl-prolinamide of the formula: <IMAGE> or a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions containing them. The prolinamide and the pharmaceutically acceptable salts thereof are useful for the treatment of central nervous system disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7129256-B2 |
| priorityDate |
1984-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |